Skip to main content
Article
The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
Cardiovascular Drugs and Therapy (2017)
  • Robert S Rosenson, Icahn School of Medicine at Mount Sinai
  • Kate Miller, Optum Patient Insights, Lincoln, RI, USA.
  • Martha Bayliss, Optum Patient Insights, Johnston, RI, USA.
  • Robert J Sanchez, Regeneron
  • Marie T Baccara-Dinet, Sanofi, Montpellier, France.
  • Daniela Chibedi-De-Roche, Sanofi, Paris, France.
  • Beth Taylor, Hartford Hospital
  • Irfan Khan, Sanofi, Bridgewater, NJ, USA.
  • Garen Manvelian, Regeneron
  • Michelle White, Optum Patient Insights, Lincoln, RI, USA.
  • Terry A. Jacobson, Emory University
Publication Date
April 1, 2017
DOI
10.1007/S10557-017-6723-4
Citation Information
Robert S Rosenson, Kate Miller, Martha Bayliss, Robert J Sanchez, et al.. "The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability." Cardiovascular Drugs and Therapy Vol. 31 Iss. 2 (2017) p. 179 - 186
Available at: http://works.bepress.com/robert-sanchez/16/